20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Akso Health Group ADR (AHG) operates in the MEDICAL DISTRIBUTION industry and is headquartered in Qingdao, China with about 12 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2026-03-31, AHG reported $14M in revenue and ($19M) in net income.
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China.
Interactive charts & full statements → Open the AHG valuation workbench →
| Income statement | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $7M | $14M | $15M | $2M | $13M | $6M | $2M | $7M | $61M | $107M | $23M | $12M | $5M |
| Gross Profit | ($1M) | $0M | $0M | $0M | $1M | $1M | $1M | $7M | $54M | $99M | $18M | $10M | $3M |
| Gross Margin % | -9.3% | -0.1% | -1.9% | 5.1% | 9.6% | 14.5% | 69.0% | 100.0% | 87.9% | 92.1% | 77.5% | 80.2% | 65.4% |
| Operating Income (EBIT) | ($19M) | ($4M) | ($166M) | ($9M) | ($14M) | ($15M) | ($27M) | ($48M) | $5M | $76M | $10M | $4M | $0M |
| Operating Margin % | -281.9% | -28.9% | -1125.4% | -357.8% | -108.2% | -239.8% | -1547.0% | -695.7% | 8.3% | 70.7% | 43.2% | 34.8% | -6.4% |
| Net Income | ($27M) | ($19M) | ($135M) | ($9M) | ($1M) | ($17M) | ($35M) | ($71M) | $6M | $65M | $9M | $4M | $0M |
| Net Margin % | -400.5% | -135.0% | -913.4% | -391.8% | -10.3% | -267.0% | -1984.5% | -1029.7% | 9.0% | 61.1% | 37.4% | 29.8% | -7.5% |
| EBITDA | ($1M) | ($2M) | ($2M) | ($9M) | ($14M) | ($16M) | ($29M) | ($44M) | $6M | $76M | $10M | $4M | $0M |
| Earnings Per Share (EPS) | $-0.04 | $-0.03 | $-0.47 | $-0.40 | $-0.18 | $-0.85 | $-6.42 | $-13.14 | $0.94 | $12.37 | $1.61 | $0.66 | $-0.07 |
| Shares Outstanding (M) | 723M | 723M | — | 24M | 8M | 20M | 5M | 5M | 6M | 5M | 5M | 5M | 5M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-06-30 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $3M | $3M | $4M | $4M | $3M | $1M | $0M | $1M |
| Gross Profit | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Margin % | -9.3% | -9.3% | -6.0% | -6.0% | 2.8% | 5.5% | 4.3% | 10.8% |
| Operating Income (EBIT) | ($10M) | ($10M) | ($83M) | ($83M) | $0M | ($3M) | ($1M) | ($7M) |
| Operating Margin % | -281.9% | -281.9% | -2113.4% | -2113.4% | -7.8% | -415.7% | -259.2% | -1060.5% |
| Net Income | ($19M) | ($9M) | ($67M) | ($67M) | $0M | ($3M) | ($2M) | ($7M) |
| Net Margin % | -546.5% | -254.6% | -1713.4% | -1713.4% | -8.5% | -394.2% | -342.9% | -1119.5% |
| EBITDA | ($1M) | ($1M) | ($1M) | ($1M) | $0M | $0M | ($7M) | ($7M) |
| Earnings Per Share (EPS) | $-0.03 | $-0.03 | $-0.20 | $-0.20 | — | — | — | — |
| Shares Outstanding (M) | 723M | 285M | 337M | 337M | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($20M) | ($13M) | $1M | $1M | ($3M) | ($9M) | $10M | ($56M) | ($2M) | $88M | $8M | $7M | $3M |
| Capital Expenditures (CapEx) | $88M | $176M | $0M | $0M | $0M | $0M | $0M | $0M | $1M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | ($108M) | ($188M) | $1M | $1M | ($3M) | ($9M) | $10M | ($56M) | ($3M) | $87M | $8M | $7M | $2M |
| FCF Margin % | -1575.2% | -1362.5% | 6.9% | 56.0% | -24.7% | -136.8% | 572.9% | -812.5% | -4.4% | 81.4% | 34.5% | 58.1% | 50.8% |
| Dividends Paid | — | — | — | — | — | — | $0M | $0M | $20M | $20M | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-06-30 | 2023-12-31 | 2023-06-30 |
|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($13M) | ($7M) | $3M | $3M | ($2M) | $1M | $0M |
| Capital Expenditures (CapEx) | $0M | $88M | $0M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | ($13M) | ($95M) | $3M | $3M | ($2M) | $1M | $0M |
| FCF Margin % | -374.4% | -2776.0% | 76.5% | 76.5% | -71.8% | 72.9% | 27.1% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $190M | $190M | $215M | $142M | $20M | $51M | $32M | $80M | $173M | $164M | $28M | $22M | $7M |
| Cash & Cash Equivalents | $0M | $0M | $176M | $85M | $8M | $22M | $15M | $7M | $57M | $133M | $19M | $8M | $1M |
| Total Liabilities | $9M | $9M | $16M | $4M | $12M | $38M | $14M | $32M | $47M | $24M | $5M | $8M | $4M |
| Total Debt (Short + Long-Term) | $0M | $0M | $0M | $2M | $10M | $0M | $10M | $21M | $20M | $0M | $0M | $0M | $0M |
| Total Shareholders' Equity | $181M | $181M | $199M | $138M | $9M | $12M | $17M | $48M | $127M | $140M | $24M | $14M | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AHG viewer.
About TickerBase · Data methodology & sources · Privacy · Terms